Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

11 November 2015 : Clinical Research  

High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification

Xiao FuABCDEF, Qin-Qin CuiBCD, Jian-Ping NingABCDFG, Shuang-Shuang FuB, Xiao-Hua LiaoB

DOI: 10.12659/MSM.894894

Med Sci Monit 2015; 21:3467-3473

Abstract

BACKGROUND: High- and low-flux hemodialysis (HFHD and LFHD, respectively) are dialysis procedures designed to eliminate blood toxins that accumulate in end-stage renal disease. HFHD may reduce vascular calcification by removing serum fibroblast growth factor 23 (FGF-23). However, whether HFHD is better than LFHD is still under debate. We therefore compared the efficacy of HFHD and LFHD in controlling FGF-23 and vascular calcification.

MATERIAL AND METHODS: Fifty hemodialysis patients were recruited and randomly treated with either HFHD or LFHD. Fasting venous blood was collected at baseline, six months, and twelve months after the treatment. We then measured levels of FGF-23, calcium, phosphorus, parathyroid hormone, and alkaline phosphatase. Further, abdominal lateral radiographs were taken to calculate aorta abdominalis calcification scores (AACs).

RESULTS: Compared to the LFHD group, FGF-23 and AACs in the HFHD group significantly decreased after 12 months treatment (p=0.049 and p=0.002, respectively). AACs were positively correlated with FGF-23 in all patients (p=0.004), the HFHD group alone (p=0.040), and the LFHD group alone (p=0.037). We also found that older patients, patients with higher blood phosphorus levels, and higher FGF-23 levels had an increased risk of aorta abdominalis calcification (p=0.048, p=0.003, p=0.001, respectively). HFHD was more able to reduce the risk of aorta abdominalis calcification than LFHD (p=0.003).

CONCLUSIONS: FGF-23 is an independent risk factor for the development of vascular calcification. HFHD may benefit hemodialysis patients by reducing serum FGF-23 levels and controlling vascular calcification.

Keywords: Alkaline Phosphatase - metabolism, Aorta, Abdominal - pathology, Calcium - blood, Fibroblast Growth Factors - blood, Gene Expression Regulation, Kidney Failure, Chronic - therapy, Parathyroid Hormone - blood, Phosphorus - blood, Radiography, Abdominal, Regression Analysis, Renal Dialysis, Renal Insufficiency, Chronic - therapy, Risk Factors, Vascular Calcification - blood

Add Comment 0 Comments

Editorial

01 January 2025 : Editorial  

Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?

Dinah V. Parums

DOI: 10.12659/MSM.947707

Med Sci Monit 2025; 31:e947707

0:00

In Press

Animal Research  

Role of the Dorsal Cortex of the Inferior Colliculus in the Precedence Effect

Med Sci Monit In Press; DOI: 10.12659/MSM.945605  

0:00

Laboratory Research  

Comparative Evaluation of the Dimensional Accuracy of Silicone-Based Putty Reline Impressions with Differen...

Med Sci Monit In Press; DOI: 10.12659/MSM.946537  

Clinical Research  

Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Oc...

Med Sci Monit In Press; DOI: 10.12659/MSM.945937  

Review article  

COL3A1 Gene Polymorphism and Its Impact on Female Pelvic Organ Prolapse

Med Sci Monit In Press; DOI: 10.12659/MSM.946367  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,962,174

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   699,683

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   22,873

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   17,628

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750